PACB Pacific Biosciences of California
Company Analysis
Latest News
🟢 Pacific Biosciences is trading 10.4% up on October 27, 2026 amid broader biotech and market strength
Pacific Biosciences is trading 10.44% up at $2.48 on October 27, 2026, with no clear company-specific announcement identified to explain the move. - The...
🟢 Pacific Biosciences is trading 5.6% up with no clear catalyst identified
Pacific Biosciences is trading at $2.38, up 5.56%, with no clear, specific catalyst identified for the October 27 move. - No October 27 announcement appears...
🟢 Pacific Biosciences is trading 5% up today amid gains across major U.S. indexes
Pacific Biosciences is trading 5.03% higher at $2.22, while major U.S. indexes are also higher, supporting a broader risk-on backdrop. - The company’s...
🟢 Pacific Biosciences is trading 10.92% up today amid biotech-sector strength
Pacific Biosciences is trading at $2.17, up 10.92%, with biotech-sector strength a likely tailwind; available evidence points more to sector sentiment than a...
🟢 Pacific Biosciences is trading 5.87% up today alongside XBI's 2.10% regular-session gain
Pacific Biosciences is trading at $2.08, up 5.87%, with biotech-sector strength offering a possible tailwind. - The supplied sector update puts XBI up 2.10%...
PacBio's Verily Deal Wraps AI Buzz Around a Money-Losing Business — But Can a Partnership Without Dollar Signs Actually Move the Needle?
Shares of Pacific Biosciences surged 10.1% to $2.02 on October 20, extending a two-day rally of roughly 17%, after the company announced a multi-year...
🟢 Pacific Biosciences is trading 10% up today after announcing multi-year Verily collaboration
Pacific Biosciences is trading up 10.05% at $2.02 on October 20, with the rally linked to its October 19 multi-year collaboration with Verily Health. - The...
🟢 Pacific Biosciences is trading 6.36% up today amid Verily Health collaboration on AI-ready genomic datasets
Pacific Biosciences is trading at $1.96, up 6.36%, with the Verily Health collaboration the clearest company-specific catalyst in available reporting. - The...
🟢 Pacific Biosciences is trading 6.35% up amid Verily Health collaboration on AI-ready genomic datasets
Pacific Biosciences is trading 6.35% higher at $1.84 on October 19, 2026, amid its announced multi-year collaboration with Verily Health to create AI-ready...
🔴 Pacific Biosciences is trading 10.2% down with no identified company catalyst
Pacific Biosciences is trading 10.2% down now at $1.76, with no clear company-specific announcement explaining the October 16 drop. - MarketWatch also...
🔴 Pacific Biosciences is trading 7% down today amid biotech sector weakness
Pacific Biosciences is trading 7.4% down at $1.81, alongside weakness across the biotech sector. - Biotech ETF XBI is down 2.06% during the regular session. -...
🔴 Pacific Biosciences is trading 10.1% down with no confirmed catalyst identified
Pacific Biosciences is trading 10.1% down at $2.10 on October 12, 2026, with no confirmed company-specific catalyst identified. - The latest company...
🔴 Pacific Biosciences is trading 6.4% down with no confirmed catalyst
Pacific Biosciences is trading 6.4% lower at $2.18, with no confirmed catalyst identified for the October 12 decline. - Latest company news located was an...
🟢 Pacific Biosciences is trading 6.1% up
Pacific Biosciences is trading 6.1% up at $2.44 on October 9, recovering from its October 8 close of $2.30, which was down 15.44%. - No new company-specific...
🔴 Pacific Biosciences is trading 11.73% down today amid biotech weakness and rising oil prices
Pacific Biosciences is trading 11.73% lower at $2.40 as biotech shares weaken and oil prices rise, though no company-specific cause for the October 8 decline...
🔴 Pacific Biosciences is trading 6% down today amid rising oil prices and elevated Treasury yields
Pacific Biosciences is trading at $2.56, down 5.88%, with broader market pressure potentially contributing to the decline. - No new company-specific...
🔴 Pacific Biosciences is trading 5.4% down
Pacific Biosciences is trading 5.37% down at $2.58 on October 7, 2026; no new company-specific catalyst was identified. - October 6 TychoBio collaboration...
PacBio Teams With TychoBio to Train RNA-Therapy AI on 10,000+ Samples
Pacific Biosciences of California (PacBio) announced a collaboration with AI drug discovery company TychoBio to advance RNA therapies for rare diseases....
🔴 Pacific Biosciences is trading 6.3% down in pre-market amid a pullback after recent gains
Pacific Biosciences is trading 6.3% down in pre-market at $2.53 on October 7, amid a pullback after a recent rally. - Shares climbed from $1.71 on September...
🔴 Pacific Biosciences is trading 10.98% down today with biotech-sector weakness a likely factor
Pacific Biosciences is trading 10.98% lower at $2.56, with biotech-sector weakness a likely contributor but no clear company-specific negative catalyst...